Medy-Tox Inc. (KOSDAQ:086900)
118,600
-2,100 (-1.74%)
Oct 10, 2025, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 832.50 billion as of October 10, 2025. Its market cap has decreased by -29.41% in one year.
Market Cap
832.50B
Enterprise Value
866.42B
Revenue
234.63B
Ranking
n/a
PE Ratio
41.87
Stock Price
118,600.00
Market Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 832.50B, an increase of 1,060.68%. That is a compound annual growth rate of 15.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 832.50B | 0.17% |
Dec 30, 2024 | 831.10B | -48.75% |
Dec 28, 2023 | 1,621.72B | 101.16% |
Dec 29, 2022 | 806.18B | -7.99% |
Dec 30, 2021 | 876.20B | -13.91% |
Dec 30, 2020 | 1,017.74B | -39.32% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.81T |
Celltrion | 38.64T |
ALTEOGEN | 25.22T |
Yuhan | 8,969.60B |
SK Biopharmaceuticals | 8,144.58B |
Peptron | 7,006.86B |
PharmaResearch | 5,714.31B |
LigaChem Biosciences | 5,545.53B |